Literature DB >> 26515554

Pathophysiology of lipid droplet proteins in liver diseases.

Rotonya M Carr1, Rexford S Ahima2.   

Abstract

Cytosolic lipid droplets (LDs) are present in most cell types, and consist of a core comprising neutral lipids, mainly triglycerides and sterol esters, surrounded by a monolayer of phospholipids. LDs are heterogeneous in their structure, chemical composition, and tissue distribution. LDs are coated by several proteins, including perilipins and other structural proteins, lipogenic enzymes, lipases and membrane-trafficking proteins. Five proteins of the perilipin (PLIN) family (PLIN1 (perilipin), PLIN2 (adipose differentiation-related protein), PLIN3 (tail-interacting protein of 47kDa), PLIN4 (S3-12), and PLIN5 (myocardial lipid droplet protein)), are associated with LD formation. More recently, the CIDE family of proteins, hypoxia-inducible protein 2 (HIG2), and patanin-like phospholipase domain-containing 3 (PNPLA3) have also gained attention in hepatic LD biology. Evidence suggests that LD proteins are involved in the pathophysiology of fatty liver diseases characterized by excessive lipid accumulation in hepatocytes. This review article will focus on how hepatic LDs and their associated proteins are involved in the pathogenesis of three chronic liver conditions: hepatitis C virus infection, non-alcoholic fatty liver disease, and alcoholic liver disease.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcohol; Diabetes; HCV; Hepatitis; Lipid droplet; Lipids; Liver; NAFLD; Obesity; Perilipin; Steatosis

Mesh:

Substances:

Year:  2015        PMID: 26515554      PMCID: PMC4744586          DOI: 10.1016/j.yexcr.2015.10.021

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  62 in total

1.  The Lipid Droplet Protein Hypoxia-inducible Gene 2 Promotes Hepatic Triglyceride Deposition by Inhibiting Lipolysis.

Authors:  Marina T DiStefano; Laura V Danai; Rachel J Roth Flach; Anil Chawla; David J Pedersen; Adilson Guilherme; Michael P Czech
Journal:  J Biol Chem       Date:  2015-04-28       Impact factor: 5.157

2.  Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.

Authors:  Jennifer E Lambert; Maria A Ramos-Roman; Jeffrey D Browning; Elizabeth J Parks
Journal:  Gastroenterology       Date:  2013-12-04       Impact factor: 22.682

3.  PNPLA3 mediates hepatocyte triacylglycerol remodeling.

Authors:  Hanna Ruhanen; Julia Perttilä; Maarit Hölttä-Vuori; You Zhou; Hannele Yki-Järvinen; Elina Ikonen; Reijo Käkelä; Vesa M Olkkonen
Journal:  J Lipid Res       Date:  2014-02-07       Impact factor: 5.922

4.  Cell death-inducing DFFA-like effector b is required for hepatitis C virus entry into hepatocytes.

Authors:  Xianfang Wu; Emily M Lee; Christy Hammack; Jason M Robotham; Mausumi Basu; Jianshe Lang; Margo A Brinton; Hengli Tang
Journal:  J Virol       Date:  2014-05-14       Impact factor: 5.103

Review 5.  PNPLA3 I148M polymorphism and progressive liver disease.

Authors:  Paola Dongiovanni; Benedetta Donati; Roberta Fares; Rosa Lombardi; Rosellina Margherita Mancina; Stefano Romeo; Luca Valenti
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

6.  Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome.

Authors:  Mahesh K Basantani; Mitch T Sitnick; Lingzhi Cai; Daniel S Brenner; Noah P Gardner; John Zhong Li; Gabriele Schoiswohl; Kui Yang; Manju Kumari; Richard W Gross; Rudolf Zechner; Erin E Kershaw
Journal:  J Lipid Res       Date:  2010-11-09       Impact factor: 5.922

7.  Global distribution and prevalence of hepatitis C virus genotypes.

Authors:  Jane P Messina; Isla Humphreys; Abraham Flaxman; Anthony Brown; Graham S Cooke; Oliver G Pybus; Eleanor Barnes
Journal:  Hepatology       Date:  2014-07-28       Impact factor: 17.425

8.  Insulin resistance and white adipose tissue inflammation are uncoupled in energetically challenged Fsp27-deficient mice.

Authors:  Linkang Zhou; Shi-Young Park; Li Xu; Xiayu Xia; Jing Ye; Lu Su; Kyeong-Hoon Jeong; Jang Ho Hur; Hyunhee Oh; Yoshikazu Tamori; Cristina M Zingaretti; Saverio Cinti; Jesús Argente; Miao Yu; Lizhen Wu; Shenghong Ju; Feifei Guan; Hongyuan Yang; Cheol Soo Choi; David B Savage; Peng Li
Journal:  Nat Commun       Date:  2015-01-07       Impact factor: 14.919

9.  Absence of perilipin 2 prevents hepatic steatosis, glucose intolerance and ceramide accumulation in alcohol-fed mice.

Authors:  Rotonya M Carr; Giselle Peralta; Xiaoyan Yin; Rexford S Ahima
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

10.  Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis.

Authors:  Eriks Smagris; Soumik BasuRay; John Li; Yongcheng Huang; Ka-man V Lai; Jesper Gromada; Jonathan C Cohen; Helen H Hobbs
Journal:  Hepatology       Date:  2014-10-01       Impact factor: 17.425

View more
  52 in total

1.  Perilipin 5 and liver fatty acid binding protein function to restore quiescence in mouse hepatic stellate cells.

Authors:  Jianguo Lin; Shizhong Zheng; Alan D Attie; Mark P Keller; David A Bernlohr; William S Blaner; Elizabeth P Newberry; Nicholas O Davidson; Anping Chen
Journal:  J Lipid Res       Date:  2018-01-09       Impact factor: 5.922

Review 2.  Acidosis and cancer: from mechanism to neutralization.

Authors:  Arig Ibrahim-Hashim; Veronica Estrella
Journal:  Cancer Metastasis Rev       Date:  2019-06       Impact factor: 9.264

3.  Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.

Authors:  David J Orlicky; Andrew E Libby; Elise S Bales; Rachel H McMahan; Jenifer Monks; Francisco G La Rosa; James L McManaman
Journal:  J Physiol       Date:  2019-01-02       Impact factor: 5.182

Review 4.  Lipid droplet functions beyond energy storage.

Authors:  Michael A Welte; Alex P Gould
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-07-19       Impact factor: 4.698

Review 5.  Alcohol effects on hepatic lipid metabolism.

Authors:  Sookyoung Jeon; Rotonya Carr
Journal:  J Lipid Res       Date:  2020-02-06       Impact factor: 5.922

Review 6.  Mechanisms, biomarkers and targets for therapy in alcohol-associated liver injury: From Genetics to nutrition: Summary of the ISBRA 2018 symposium.

Authors:  Irina A Kirpich; Dennis R Warner; Wenke Feng; Swati Joshi-Barve; Craig J McClain; Devanshi Seth; Wei Zhong; Zhanxiang Zhou; Natalia A Osna; Kusum K Kharbanda
Journal:  Alcohol       Date:  2019-05-23       Impact factor: 2.405

Review 7.  CGI-58: Versatile Regulator of Intracellular Lipid Droplet Homeostasis.

Authors:  Liqing Yu; Yi Li; Alison Grisé; Huan Wang
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

8.  A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis.

Authors:  Bianca Williams; Jason Correnti; Amanke Oranu; Annie Lin; Victoria Scott; Maxine Annoh; James Beck; Emma Furth; Victoria Mitchell; Can E Senkal; Lina Obeid; Rotonya M Carr
Journal:  FASEB J       Date:  2017-09-01       Impact factor: 5.191

9.  Rapid Lipid Droplet Isolation Protocol Using a Well-established Organelle Isolation Kit.

Authors:  Jascha Brettschneider; Jason M Correnti; Chelsea Lin; Bianca Williams; Amanke Oranu; Amy Kuriakose; Dru McIver-Jenkins; Abigail Haba; Isabelle Kaneza; Sookyoung Jeon; Eleonora Scorletti; Rotonya M Carr
Journal:  J Vis Exp       Date:  2019-04-19       Impact factor: 1.355

10.  ILRUN, a Human Plasma Lipid GWAS Locus, Regulates Lipoprotein Metabolism in Mice.

Authors:  Xin Bi; Takashi Kuwano; Paul C Lee; John S Millar; Li Li; Yachen Shen; Raymond E Soccio; Nicholas J Hand; Daniel J Rader
Journal:  Circ Res       Date:  2020-09-11       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.